Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 10344281
Functionally-modified oligonucleotides and subunits thereof
granted -
US 10342771
Creatine oral supplementation using creatine hydrochloride salt
granted -
US 10343995
Biphenyl compounds useful as muscarinic receptor antagonists
granted -
US 10342786
P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
granted -
US 10342815
GLA monotherapy for use in cancer treatment
granted -
US 10335402
Sulfonyl piperidine derivatives and their use for treating prokineticin mediated gastrointestinal disorders
granted -
US 10336773
Neprilysin inhibitors
granted -
US 10335365
Bladder cancer specific ligand peptides
granted -
US 10336833
Conjugated anti-CD38 antibodies
granted -
US 10335460
IL-15 and IL-15Rα heterodimer dose escalation regimens for treating conditions
granted -
US 10336786
Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway
granted -
US 10335423
Inhibition of HIV infection through chemoprophylaxis
granted -
US 10335404
Methods of treating cancer patients with farnesyltransferase inhibitors
granted -
US 10335458
Pharmaceutical compositions for treating or preventing bone conditions
granted -
US 10335440
Direct-fed microbials
granted -
US 10335426
N-acetyl mannosammine as a therapeutic agent
granted -
US 10337010
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
granted -
US 10337005
Oligonucleotide-based inhibitors comprising locked nucleic acid motif
granted -
US 10336864
Production method for poly(amino acid)
granted -
US 10337003
Compositions for treating muscular dystrophy
granted -
US 10336732
1-heterocyclyl isochromanyl compounds and analogs for treating CNS disorders
granted -
US 10335491
Catalytic delivery nanosubstrates (CDNS) for highly efficient delivery of biomolecules
granted -
US 10335382
Use of hydrogen sulfide synthesis inhibitors for cancer therapy
granted -
US 10335368
Ultrasound-triggerable agents for tissue engineering
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.